Literature DB >> 32015874

HCV Burden and Barriers to Elimination in the Middle East.

Sarah Blach1, Faisal M Sanai2.   

Abstract

Year:  2020        PMID: 32015874      PMCID: PMC6988416          DOI: 10.1002/cld.897

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


× No keyword cloud information.
  7 in total

Review 1.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

2.  Strategies to manage hepatitis C virus infection disease burden - volume 3.

Authors:  F Z Alfaleh; N Nugrahini; M Matičič; I Tolmane; M Alzaabi; B Hajarizadeh; J Valantinas; D Y Kim; B Hunyady; F Abaalkhail; Z Abbas; A Abdou; A Abourached; F Al Braiki; F Al Hosani; K Al Jaberi; M Al Khatry; M A Al Mulla; H Al Quraishi; A Al Rifai; Y Al Serkal; A Alam; H I Alashgar; S M Alavian; S Alawadhi; L Al-Dabal; P Aldins; A S Alghamdi; R Al-Hakeem; A A Aljumah; A Almessabi; A N Alqutub; K A Alswat; I Altraif; N Andrea; A M Assiri; M A Babatin; A Baqir; M T Barakat; O M Bergmann; A R Bizri; A Chaudhry; M S Choi; T Diab; S Djauzi; E S El Hassan; S El Khoury; C Estes; S Fakhry; J I Farooqi; H Fridjonsdottir; R A Gani; A Ghafoor Khan; L Gheorghe; A Goldis; M Gottfredsson; S Gregorcic; J Gunter; S Hamid; K H Han; I Hasan; A Hashim; G Horvath; R Husni; W Jafri; A Jeruma; J G Jonasson; B Karlsdottir; Y S Kim; Z Koutoubi; L A Lesmana; V Liakina; Y S Lim; A Löve; M Maimets; M Makara; R Malekzadeh; M S Memon; S Merat; J E Mokhbat; F H Mourad; D H Muljono; A Nawaz; S Olafsson; S Priohutomo; H Qureshi; P Rassam; H Razavi; D Razavi-Shearer; K Razavi-Shearer; B Rozentale; M Sadik; K Saeed; A Salamat; R Salupere; F M Sanai; A Sanityoso Sulaiman; R A Sayegh; J D Schmelzer; A I Sharara; A Sibley; M Siddiq; A M Siddiqui; G Sigmundsdottir; B Sigurdardottir; D Speiciene; A Sulaiman; M A Sultan; M Taha; J Tanaka; H Tarifi; G Tayyab; M Ud Din; M Umar; J Videčnik-Zorman; C Yaghi; E Yunihastuti; M A Yusuf; B F Zuberi; S Blach
Journal:  J Viral Hepat       Date:  2015-12       Impact factor: 3.728

3.  EASL Recommendations on Treatment of Hepatitis C 2018.

Authors: 
Journal:  J Hepatol       Date:  2018-04-09       Impact factor: 25.083

4.  Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.

Authors:  Sarah Kattakuzhy; Chloe Gross; Benjamin Emmanuel; Gebeyehu Teferi; Veronica Jenkins; Rachel Silk; Elizabeth Akoth; Aurielle Thomas; Charisse Ahmed; Michelle Espinosa; Angie Price; Elana Rosenthal; Lydia Tang; Eleanor Wilson; Soren Bentzen; Henry Masur; Shyam Kottilil
Journal:  Ann Intern Med       Date:  2017-08-08       Impact factor: 25.391

5.  Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.

Authors:  A J Wade; A McCormack; C Roder; K McDonald; M Davies; N Scott; M Wardrop; E Athan; M E Hellard
Journal:  J Viral Hepat       Date:  2018-05-08       Impact factor: 3.728

6.  Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis.

Authors:  Sarwat Mahmud; Silva P Kouyoumjian; Zaina Al Kanaani; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Ann Epidemiol       Date:  2018-03-21       Impact factor: 3.797

7.  Strategies to manage hepatitis C virus infection disease burden-Volume 4.

Authors:  D S Chen; W Hamoudi; B Mustapha; J Layden; A Nersesov; T Reic; V Garcia; C Rios; L Mateva; O Njoya; S A Al-Busafi; M K Abdelmageed; M Abdulla; D Adda; O Akin; A Al Baqali; N Al Dweik; K Al Ejji; I Al Ghazzawi; S Al Kaabi; K Al Naamani; J Al Qamish; M Al Sadadi; J Al Salman; M AlBadri; H E Al-Romaihi; W Ampofo; K Antonov; C Anyaike; F Arome; A Bane; S Blach; M M Borodo; S M Brandon; B Bright; M T Butt; I Cardenas; H L Y Chan; C J Chen; P J Chen; R N Chien; W L Chuang; D Cuellar; M Derbala; A A Elbardiny; C Estes; E Farag; J Fung; I Gamkrelidze; J Genov; Z Ghandour; M Ghuloom; B Gomez; J Gunter; J Habeeb; O Hajelssedig; S M Himatt; I Hrstic; C C Hu; C F Huang; Y T Hui; R Jahis; D Jelev; A K John; K S Kaliaskarova; Y Kamel; J H Kao; J Khamis; H Khattabi; I Khoudri; A Konysbekova; I Kotzev; M S Lai; W C Lao; M H Lee; O Lesi; M Li; A Lo; C K Loo; B Lukšić; A Maaroufi; A O Malu; R Mitova; R Mohamed; M Morović; K Murphy; H Nde; E Ngige; R Njouom; D Nonković; S Obekpa; S Oguche; E E Okolo; O Omede; C Omuemu; P Ondoa; O Opare-Sem; S Owusu-Ofori; R O Phillips; Y N Prokopenko; H Razavi; D Razavi-Shearer; K Razavi-Shearer; B Redae; T Rinke de Wit; S Robbins; L R Roberts; S J Sanad; M Sharma; M Simonova; T H Su; K Sultan; S S Tan; K Tchernev; O T Y Tsang; S Tsang; C Tzeuton; S Ugoeze; B Uzochukwu; R Vi; A Vince; H U Wani; V W S Wong; A Workneh; R Yacoub; K I Yesmembetov; M Youbi; M F Yuen; J D Schmelzer
Journal:  J Viral Hepat       Date:  2017-10       Impact factor: 3.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.